JP2017511368A5 - - Google Patents

Download PDF

Info

Publication number
JP2017511368A5
JP2017511368A5 JP2016562898A JP2016562898A JP2017511368A5 JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5 JP 2016562898 A JP2016562898 A JP 2016562898A JP 2016562898 A JP2016562898 A JP 2016562898A JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
grams
stereoisomer
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017511368A (ja
JP6678116B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/052814 external-priority patent/WO2015159265A1/en
Publication of JP2017511368A publication Critical patent/JP2017511368A/ja
Publication of JP2017511368A5 publication Critical patent/JP2017511368A5/ja
Application granted granted Critical
Publication of JP6678116B2 publication Critical patent/JP6678116B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562898A 2014-04-18 2015-04-17 抗菌剤を含む医薬組成物 Expired - Fee Related JP6678116B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1407/MUM/2014 2014-04-18
IN1407MU2014 2014-04-18
PCT/IB2015/052814 WO2015159265A1 (en) 2014-04-18 2015-04-17 Pharmaceutical compositions comprising antibacterial agents

Publications (3)

Publication Number Publication Date
JP2017511368A JP2017511368A (ja) 2017-04-20
JP2017511368A5 true JP2017511368A5 (enExample) 2018-06-07
JP6678116B2 JP6678116B2 (ja) 2020-04-08

Family

ID=53276202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562898A Expired - Fee Related JP6678116B2 (ja) 2014-04-18 2015-04-17 抗菌剤を含む医薬組成物

Country Status (8)

Country Link
US (1) US10857138B2 (enExample)
EP (1) EP3131583A1 (enExample)
JP (1) JP6678116B2 (enExample)
KR (1) KR102173632B1 (enExample)
CN (1) CN107980000A (enExample)
BR (1) BR112016024235A2 (enExample)
MX (1) MX2016013431A (enExample)
WO (1) WO2015159265A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10417727B2 (en) * 2016-09-26 2019-09-17 Uber Technologies, Inc. Network system to determine accelerators for selection of a service
EP3301094A1 (en) * 2016-09-30 2018-04-04 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
JP7012924B2 (ja) * 2017-03-02 2022-02-15 ウォックハート リミテッド 抗菌化合物としての複素環誘導体
US10085999B1 (en) * 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
TW201925201A (zh) * 2017-11-10 2019-07-01 日商鹽野義製藥股份有限公司 二氮雜二環辛烷衍生物
EP3744722A4 (en) 2018-01-25 2021-11-03 Suzhou Sinovent Pharmaceuticals Co., Ltd. Ss-LACTAMASE INHIBITOR AND ITS USE
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
KR102790878B1 (ko) 2018-08-09 2025-04-02 앤타바이오 에스에이에스 세린 베타-락타마제의 억제제로서 다이아자바이사이클로옥타논
EP4434988A4 (en) 2021-11-17 2026-01-28 Evopoint Biosciences Co Ltd β-Lactamase Inhibitor Intermediate and its Preparation Process

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US342553A (en) * 1886-05-25 Induction-coil
US2874279A (en) 1952-08-06 1959-02-17 Itt Pulse selector circuit
KR101512738B1 (ko) * 2011-08-27 2015-04-17 욱크하르트 리미티드 1,6-디아자-비시클로[3,2,1]옥탄-7-온 유도체 및 세균 감염 치료에서의 그 유도체의 용도
KR101618424B1 (ko) * 2011-08-30 2016-05-04 욱크하르트 리미티드 1,6-디아자비시클로[3,2,1]옥탄-7-온 유도체 및 세균 감염 치료에서의 그 유도체의 용도
BR112014003476A2 (pt) 2011-09-13 2017-03-01 Wockhardt Ltd compostos contendo nitrogênio e seu uso
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
KR20140144254A (ko) 2012-03-30 2014-12-18 큐비스트 파마슈티컬즈 인코포레이티드 1,3,4-옥사디아졸 및 1,3,4-티아디아졸 β-락타마제 억제제
US8916709B2 (en) * 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
AR091222A1 (es) 2012-05-30 2015-01-21 Meiji Seika Pharma Co Ltd INHIBIDOR DE b-LACTAMASA Y PROCESO PARA PREPARARLO
US9433613B2 (en) * 2013-01-14 2016-09-06 Wockhardt Limited Compositions and methods for treating bacterial infections

Similar Documents

Publication Publication Date Title
JP2009534386A5 (enExample)
JP2012533546A5 (enExample)
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина
CN105919998B (zh) 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
JP2019526596A5 (enExample)
JP2012513416A5 (enExample)
JP2019524883A5 (enExample)
JP2018528244A5 (enExample)
SI3018132T1 (en) Condensed imidazole derivatives useful as IDO inhibitors
JP2014528464A5 (enExample)
JP2010524932A5 (enExample)
JP2017505293A5 (enExample)
JP2012532136A5 (enExample)
JP2015501833A5 (enExample)
JP2016534148A5 (enExample)
JP2016540742A5 (enExample)
JP2014534981A5 (enExample)
JP2014509600A5 (enExample)
JP2011509301A5 (enExample)
JP2013542267A5 (enExample)
JP2014510147A5 (enExample)
JP2010132677A5 (enExample)
JP2016540811A5 (enExample)
JP2013537240A5 (enExample)
JP2014532754A5 (enExample)